Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients

NCT03686202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

All Solid Tumors

Interventions

BIOLOGICAL: MET-4

Sponsor

University Health Network, Toronto

Collaborators

[object Object]